Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Industrials | 8.98% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Photronics
PLAB
$1.9B
| $5.27M | 0.01% |
223,788
+29,193
| +15% | +$715K |
|
1427
Angi Inc
ANGI
$248M
| $5.25M | 0.01% |
316,488
-8,706
| -3% | -$186K |
|
1428
Flywire
FLYW
$2.09B
| $5.25M | 0.01% |
254,400
+189,521
| +292% | +$3.7M |
|
1429
Albemarle
ALB
$14.1B
| $5.23M | 0.01% |
60,800
+58,100
| +2,152% | +$5.79M |
|
1430
Laureate Education
LAUR
$5.21B
| $5.23M | 0.01% |
285,800
+275,600
| +2,702% | +$4.83M |
|
1431
LivaNova
LIVN
$4.54B
| $5.21M | 0.01% |
112,594
+9,500
| +9% | +$487K |
|
1432
Kura Oncology
KURA
$829M
| $5.21M | 0.01% |
597,810
+491,700
| +463% | +$7.08M |
|
|
HIMX
1433
Himax Technologies
HIMX
$2.41B
| $5.16M | 0.01% |
641,595
-40,552
| -6% | -$256K |
|
|
DX
1434
Dynex Capital
DX
$3.13B
| $5.15M | 0.01% |
407,400
-83,500
| -17% | -$1.04M |
|
1435
Friedman Industries
FRD
$247M
| $5.15M | 0.01% |
336,782
-22,400
| -6% | -$341K |
|
1436
Geron
GERN
$860M
| $5.14M | 0.01% |
+1,452,700
| New | +$5.8M |
|
|
AAT
1437
American Assets Trust
AAT
$1.44B
| $5.13M | 0.01% |
195,200
+103,500
| +113% | +$2.83M |
|
1438
CarGurus
CARG
$3.41B
| $5.11M | 0.01% |
139,827
+116,527
| +500% | +$4M |
|
1439
Unisys
UIS
$222M
| $5.1M | 0.01% |
805,800
+30,400
| +4% | +$212K |
|
1440
HF Sinclair
DINO
$15.5B
| $5.08M | 0.01% |
144,905
+64,800
| +81% | +$2.65M |
|
1441
Koppers
KOP
$976M
| $5.07M | 0.01% |
156,632
+78,732
| +101% | +$2.81M |
|
1442
Lufax Holding
LU
$1.33B
| $5.07M | 0.01% |
2,122,819
-43,500
| -2% | -$120K |
|
1443
Kamada
KMDA
$420M
| $5.07M | 0.01% |
831,913
-24,193
| -3% | -$139K |
|
1444
American Outdoor Brands
AOUT
$162M
| $5.06M | 0.01% |
331,768
+60,600
| +22% | +$653K |
|
1445
Knowles
KN
$3.35B
| $5.05M | 0.01% |
253,600
+18,826
| +8% | +$350K |
|
1446
Vertex
VERX
$1.89B
| $5.05M | 0.01% |
94,700
-214,800
| -69% | -$10.4M |
|
1447
Wyndham Hotels & Resorts
WH
$5.69B
| $5.05M | 0.01% |
50,100
+25,500
| +104% | +$2.37M |
|
1448
Evercore
EVR
$12.5B
| $5.04M | 0.01% |
18,200
+16,800
| +1,200% | +$4.76M |
|
1449
Talkspace
TALK
$873M
| $5.04M | 0.01% |
1,632,300
-240,300
| -13% | -$731K |
|
1450
Rigel Pharmaceuticals
RIGL
$705M
| $5.04M | 0.01% |
299,709
+157,763
| +111% | +$3.03M |
|
Similar funds
Renaissance Technologies's Q4 2024 Portfolio in Review
As of Q4 2024, Renaissance Technologies held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Renaissance Technologies added most to Alibaba in Q4 2024, an estimated $191M increase.
- Renaissance Technologies's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Renaissance Technologies fully exited Arm in Q4 2024, selling an estimated $153M.
- Renaissance Technologies's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Renaissance Technologies opened 548 new positions and closed 497 in Q4 2024.
- Renaissance Technologies's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.